Back to search

Article

Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells

2023-05-26

Abstract excerpt

Backgroud: Trastuzumab is the only approved target agent for the first-line treatment of human epidermal growth factor receptor-2 (HER-2) positive gastric cancer; however, trastuzumab resistance is a major problem in clinical practice. To comprehend the mechanism of trastuzumab resistance, we focused on the Wnt/β-catenin signaling pathway and its influence on the phenotypes and behavior of trastuzumab-resistant g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22991c59-ad5f-5d71-a5bd-77a4472125c1
DOI
10.21203/rs.3.rs-2946372/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cellsDOI 10.21203/rs.3.rs-2946372/v1
Select a neighboring publication to make it the new centre.